Advanced Proteome Therapeutics Corp (APTCF)

0.0002 0.00 (0.00%) USD  |  OTCM  |  May 03, 16:00
More

Advanced Proteome Therapeutics PE Ratio

PE Ratio Chart

Historical PE Ratio Data

View and export this data back to 2015. Upgrade now.
Date Value
July 22, 2022 2.232
July 21, 2022 2.232
July 20, 2022 2.232
July 19, 2022 2.232
July 18, 2022 2.232
July 15, 2022 2.232
July 14, 2022 2.232
July 13, 2022 2.232
July 12, 2022 2.232
July 11, 2022 2.232
July 08, 2022 2.232
July 07, 2022 2.232
July 06, 2022 2.232
July 05, 2022 2.232
July 01, 2022 2.232
June 30, 2022 2.232
June 29, 2022 2.235
June 28, 2022 2.234
June 17, 2022 2.472
June 16, 2022 2.472
June 15, 2022 2.472
June 14, 2022 2.472
June 13, 2022 2.472
June 10, 2022 2.472
June 09, 2022 2.472
Date Value
June 08, 2022 2.472
June 07, 2022 2.472
June 06, 2022 2.472
June 03, 2022 2.472
June 02, 2022 2.472
June 01, 2022 2.472
May 31, 2022 2.472
May 27, 2022 2.472
May 26, 2022 2.472
April 08, 2022
April 07, 2022
April 06, 2022
April 05, 2022
April 04, 2022
April 01, 2022
March 31, 2022
March 30, 2022
March 29, 2022
March 28, 2022
March 25, 2022
March 24, 2022
March 23, 2022
March 22, 2022
March 21, 2022
March 18, 2022

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

2.232
Minimum
Jun 30 2022
2.472
Maximum
May 26 2022
2.345
Average
2.235
Median

PE Ratio Benchmarks

Cotinga Pharmaceuticals Inc --
Avitar Inc --
Acasti Pharma Inc --
Aurinia Pharmaceuticals Inc --
Edesa Biotech Inc --

PE Ratio Related Metrics

Price 0.0002
Market Cap 0.0082M